Challenges of Oral Medications in Patients With Advanced Breast Cancer

Seminars in Oncology Nursing

Volumn 23, Issue SUPPL. 2, 2007, Pages

  Palmieri, Frances M ^a   Barton, Debra L ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; BREAST TUMOR; FEMALE; HUMAN; INTERPERSONAL COMMUNICATION; NURSING; ORAL DRUG ADMINISTRATION; PATIENT COMPLIANCE; PATIENT EDUCATION; REMINDER SYSTEM;

ADMINISTRATION, ORAL; ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; COMMUNICATION; FEMALE; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; REMINDER SYSTEMS;

EID: 36549038587     PISSN: 07492081     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.soncn.2007.10.004     Document Type: Article

References (18)

1. Partridge A.H., Avorn J., Wang P.S., et al. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst 94 (2002) 652-661
2. Kehoe W.A., and Katz R.C. Health behaviors and pharmacotherapy. Ann Pharmacother 32 (1998) 1076-1086
3. Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev 84 (1977) 191-215
4. Rosenstock I.M., Strecher V.J., and Becker M.H. Social learning theory and the Health Belief Model. Health Educ Q 15 (1988) 175-183
5. Hollywood E., and Semple D. Nursing strategies for patients on oral chemotherapy. Oncology (Huntingt) 15 suppl 2 (2001) 37-39
6. Hartigan K. Patient education: the cornerstone of successful oral chemotherapy treatment. Clin J Oncol Nurs 7 suppl 6 (2003) 21-24
7. Waterhouse D.M., Calzone K.A., Mele C., et al. Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 11 (1993) 1189-1197
8. Grosset K.A., Reid J.L., and Grosset D.G. Medicine-taking behavior: implications of suboptimal compliance in Parkinson's disease. Mov Disord 20 (2005) 1397-1404
9. Roe C.M., Motheral B.R., Teitelbaum F., et al. Angiotensin-converting enzyme inhibitor compliance and dosing among patients with heart failure. Am Heart J 138 (1999) 818-825
10. Monane M., Bohn R.L., Gurwitz J.H., et al. Compliance with antihypertensive therapy among elderly Medicaid enrollees: the roles of age, gender, and race. Am J Public Health 86 (1996) 1805-1808
11. Avorn J., Monette J., Lacour A., et al. Persistence of use of lipid-lowering medications: a cross-national study. JAMA 279 (1998) 1458-1462
12. Lebovits A.H., Strain J.J., Schleifer S.J., et al. Patient noncompliance with self-administered chemotherapy. Cancer 65 (1990) 17-22
13. Liu G., Franssen E., Fitch M.I., et al. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 15 (1997) 110-115
14. John V., Mashru S., and Lichtman S. Pharmacological factors influencing anticancer drug selection in the elderly. Drugs Aging 20 (2003) 737-759
15. Lichtman S.M. Chemotherapy in the elderly. Semin Oncol 31 (2004) 160-174
16. Abetz L., Coombs J.H., Keininger D.L., et al. Development of the cancer therapy satisfaction questionnaire: item generation and content validity testing. Value Health suppl 1 (2005) S41-S53
17. Moore S. Facilitating oral chemotherapy treatment and compliance through patient/family-focused education. Cancer Nurs 30 (2007) 112-122
18. Macintosh P.W., Pond G.R., Pond B.J., et al. A comparison of patient adherence and preference of packaging method for oral anticancer agents using conventional pill bottles versus daily pill boxes. Eur J Cancer Care 16 (2007) 380-386